Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Dec-23
- 19-Sep-24
- 17-Oct-24
- 14-Nov-24
Select bar for recommendation details.
Recommendations | 14-Nov-24 | |
---|---|---|
Buy | 6 | |
Outperform | 8 | |
Hold | 2 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 16 analysts offering 12 month price targets for Travere Therapeutics Inc have a median target of 24.50, with a high estimate of 42.00 and a low estimate of 15.00. The median estimate represents a 34.17% increase from the last price of 18.26.
High | 130.0% | 42.00 |
Med | 34.2% | 24.50 |
Low | -17.9% | 15.00 |
Earnings history & estimates in USD
The next earnings announcement is expected on Feb 13, 2025.
Average growth rate | +7.41% |
Average growth rate | -5.37% |
More ▼
Revenue history & estimates in USD
Average growth rate | +15.08% |
Average growth rate | -2.62% |
More ▼